(Q43907284)

27 November 2017

No effect of angiotensin II AT(2)-receptor antagonist PD 123319 on cerebral blood flow autoregulation (English)

1 reference

27 November 2017

0 references

2

Paulson OB

1 reference

27 November 2017

Estrup TM

1

1 reference

PubMed ID

11881121

27 November 2017

Strandgaard S

series ordinal

3

1 reference

27 November 2017

1 September 2001

1 reference

Journal of the Renin-Angiotensin-Aldosterone System

27 November 2017

5

0 references

published in

1 reference

27 November 2017

2

1 reference

27 November 2017

3

1 reference

27 November 2017

188-192

1 reference

The renin-angiotensin system and its receptors

27 November 2017

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2001.026

Nonpeptide angiotensin AT1 and AT2 receptor ligands modulate the upper limit of cerebral blood flow autoregulation in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2001.026

Angiotensin II AT2 receptor stimulation extends the upper limit of cerebral blood flow autoregulation: agonist effects of CGP 42112 and PD 123319.

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2001.026

Agonistic and antagonistic properties of angiotensin analogs at the AT2 receptor in PC12W cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2001.026

Rapid and Repetitive Measurements of Blood Flow and Oxygen Consumption in the Rat Brain Using Intraarterial Xenon Injection

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2001.026

Blood-brain barrier studies in the rat: an indicator dilution technique with tracer sodium as an internal standard for estimation of extracerebral contamination.

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2001.026

Regional cerebral blood flow in man determined by the initial slope of the clearance of intra-arterially injected 133Xe.

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2001.026

Computerized Analysis of Cerebral Blood Flow Autoregulation in Humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2001.026

Cerebrovascular aspects of converting-enzyme inhibition I: Effects of intravenous captopril in spontaneously hypertensive and normotensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2001.026

Ceranapril and cerebral blood flow autoregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2001.026

The effect of intracarotid epinephrine, norepinephrine, and angiotensin on the regional cerebral blood flow in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2001.026

Effects of decreasing arterial blood pressure on cerebral blood flow in the baboon. Influence of the sympathetic nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2001.026

Angiotensin II AT(1) blockade normalizes cerebrovascular autoregulation and reduces cerebral ischemia in spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2001.026

Hemolysate inhibits cerebral artery relaxation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2001.026

Effects of angiotensin II on cerebral blood vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2001.026

Angiotensin II- and IV-induced changes in cerebral blood flow. Roles of AT1, AT2, and AT4 receptor subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2001.026

21 January 2018

Identifiers

DOI

10.3317/JRAAS.2001.026

1 reference

27 November 2017

1 reference

PubMed ID

11881121